Migraine Essentials

Migraine Essentials is a resource for primary care physicians, PAs and NPs as well as consumers looking for authoritative insights into the diagnosis, treatment , and challenges of migraine disease.
Migraine Essentials are intended to be short and to the point text and audio content addressing a variety of issues in migraine disease not typically found in mainstream didactic CME, including the use of alternative treatments. Migraine Essentials is intended to compliment conventional CME, not replace it.

Migraine Epidemiology, Diagnosis, and Preventive Gaps

Formal criteria for diagnosis.

Read Article

Butterbur Petasin: Standardized Petasites hybridus Extract

Butterbur Petasin serves as a rigorously tested, non-prescription preventive treatment for patients with episodic migraine.

Read Article

Pathophysiologic Targets in Migraine: Butterbur Petasin® Mechanisms

Butterbur Petasin exerts multimodal effects across key migraine pathophysiologic pathways.

Read Article

CGRP Suppression via TRP Channel Modulation

Butterbur Petasin significantly suppresses CGRP release in both the dura mater and trigeminal ganglion in a dose-dependent manner.

Read Article

Randomized Controlled Trial #1 in Episodic Migraine (Adult)

Butterbur Petasin significantly reduced migraine frequency from 3.4 to 1.8 attacks per month, compared with a smaller decrease from 2.9 to 2.6 in the placebo group.

Read Article

Randomized Controlled Trial #2 in Episodic Migraine (Adult)

Butterbur Petasin offers a clinically meaningful preventive option for adults with episodic migraine.

Read Article

Randomized Controlled Trials in Episodic Migraine (Pediatric)

Seventy-seven percent achieved a ≥50% reduction in attack frequency, with an overall 63% reduction from baseline.

Read Article

Safety Profile – Preclinical Toxicity Studies

Butterbur Petasin demonstrated no clinically relevant hepatotoxicity, even with prolonged or high-dose exposure.

Read Article

Butterbur Petasin Safety Profile: 24 Years of Pharmacovigilance and Causality Assessment

Exposure reached ~2.674 million patient-months worldwide, including ~2.04 million in US/Canada without any hepatobiliary AE reports in the latter region.

Read Article

Butterbur Petasin vs Competitors: Superior Potency and PA-Free Safety

21 commercially available butterbur supplements were analyzed.

Read Article

Third Party Lab Reports of Fraudulent Butterbur Brands

Two batch results by independent ISO 17025 laboratories

Read Article

Butterbur Petasin in Clinical Practice: Ideal Candidates & Contraindications

Butterbur Petasin is an evidence-based migraine preventive with a strong safety profile, contraindicated in pregnancy/lactation, liver disease, and Asteraceae allergies.

Read Article

Butterbur Petasin Support Tools for Clinicians and Patients

A range of resources to support healthcare providers in introducing this preventive migraine treatment to patients.

Read Article

A Natural CGRP Inhibitor for Episodic Migraine Prevention

Previously recorded non-accredited Webinar

Read Article